Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengshuo Liu

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Nature Cell Biology|September 12, 2024
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactionsXiaoxin Hao, Yichao Shen, Jun Liu, et al.
The Journal of Clinical Investigation|February 17, 2026
Inflammation- and resolution-programmed myeloid circuits govern therapeutic resistance in epithelial and mesenchymal triple-negative breast cancerLiqun Yu, Charlotte Rivas, Fengshuo Liu, et al.
Cancer Letters|June 7, 2024
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progressionTianhong Pan, Fengshuo Liu, Xiaoxin Hao, et al.
Nature Communications|January 3, 2026
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancersDiego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast CancersDiego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Immunity|March 29, 2025
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancerLiqun Yu, Keziah Liebenberg, Yichao Shen, et al.
Cancer Letters|May 30, 2026
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasisZifan Zhao, Ze-Yi Zheng, Jonathan T Lei, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Unbiased metastatic niche-labeling identifies estrogen receptor-positive macrophages as a barrier of T cell infiltration during bone colonizationZhan Xu, Fengshuo Liu, Yunfeng Ding, et al.
Signal Transduction and Targeted Therapy|May 10, 2026
iS2C2: a cointelligent platform for mechanistic discovery of disease cellular crosstalkJianting Sheng, Ju Young Ahn, Li Yang, et al.
Cell Genomics|May 24, 2025
Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonizationFengshuo Liu, Yunfeng Ding, Zhan Xu, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nature Cell Biology|September 12, 2024
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactionsXiaoxin Hao, Yichao Shen, Jun Liu, et al.
The Journal of Clinical Investigation|February 17, 2026
Inflammation- and resolution-programmed myeloid circuits govern therapeutic resistance in epithelial and mesenchymal triple-negative breast cancerLiqun Yu, Charlotte Rivas, Fengshuo Liu, et al.
Cancer Letters|June 7, 2024
BIGH3 mediates apoptosis and gap junction failure in osteocytes during renal cell carcinoma bone metastasis progressionTianhong Pan, Fengshuo Liu, Xiaoxin Hao, et al.
Nature Communications|January 3, 2026
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancersDiego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast CancersDiego A Pedroza, Xueying Yuan, Fengshuo Liu, et al.
Immunity|March 29, 2025
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancerLiqun Yu, Keziah Liebenberg, Yichao Shen, et al.
Cancer Letters|May 30, 2026
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasisZifan Zhao, Ze-Yi Zheng, Jonathan T Lei, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Unbiased metastatic niche-labeling identifies estrogen receptor-positive macrophages as a barrier of T cell infiltration during bone colonizationZhan Xu, Fengshuo Liu, Yunfeng Ding, et al.
Signal Transduction and Targeted Therapy|May 10, 2026
iS2C2: a cointelligent platform for mechanistic discovery of disease cellular crosstalkJianting Sheng, Ju Young Ahn, Li Yang, et al.
Cell Genomics|May 24, 2025
Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonizationFengshuo Liu, Yunfeng Ding, Zhan Xu, et al.
Pageof 5